Ariana Pharma, CTCLS Ink Distribution Deal for Japan | GenomeWeb

NEW YORK (GenomeWeb News) – Ariana Pharma announced today an exclusive distribution deal with CTC Laboratory Systems covering Japan.

The terms of the deal call for CTCLS to distribute Ariana's KEM data analytics software and services technology. CTCLS, based in Tokyo, is an R&D service provider, specializing in the pharmaceutical sector.

Further details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.